PeterLabs Holdings Bhd (KLSE:0171) — Market Cap & Net Worth
Market Cap & Net Worth: PeterLabs Holdings Bhd (0171)
PeterLabs Holdings Bhd (KLSE:0171) has a market capitalization of $15.89 Million (RM63.30 Million) as of July 21, 2026. Listed on the KLSE stock exchange, this Malaysia-based company holds position #25818 globally and #750 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying PeterLabs Holdings Bhd's stock price RM0.23 by its total outstanding shares 275213890 (275.21 Million). See 0171 capex reinvestment rate to understand how much of operating cash flow is reinvested back into capital assets.
PeterLabs Holdings Bhd Market Cap History: 2015 to 2026
PeterLabs Holdings Bhd's market capitalization history from 2015 to 2026. Data shows growth from $16.69 Million to $15.89 Million (1.55% CAGR).
PeterLabs Holdings Bhd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how PeterLabs Holdings Bhd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.05x
PeterLabs Holdings Bhd's market cap is 0.05 times its annual revenue
Latest Price to Earnings (P/E) Ratio
5.74x
PeterLabs Holdings Bhd's market cap is 5.74 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $16.69 Million | $73.48 Million | $3.34 Million | 0.23x | 5.00x |
| 2016 | $14.88 Million | $83.58 Million | $3.33 Million | 0.18x | 4.46x |
| 2017 | $17.98 Million | $94.73 Million | $4.01 Million | 0.19x | 4.49x |
| 2018 | $17.35 Million | $90.42 Million | $3.80 Million | 0.19x | 4.57x |
| 2019 | $12.93 Million | $96.23 Million | $4.28 Million | 0.13x | 3.03x |
| 2020 | $15.44 Million | $80.03 Million | $3.89 Million | 0.19x | 3.97x |
| 2021 | $14.46 Million | $183.82 Million | $5.48 Million | 0.08x | 2.64x |
| 2022 | $13.21 Million | $161.63 Million | $3.60 Million | 0.08x | 3.67x |
| 2023 | $14.23 Million | $186.21 Million | $1.39 Million | 0.08x | 10.27x |
| 2024 | $13.13 Million | $242.21 Million | $2.29 Million | 0.05x | 5.74x |
Competitor Companies of 0171 by Market Capitalization
Companies near PeterLabs Holdings Bhd in the global market cap rankings as of July 21, 2026.
Key companies related to PeterLabs Holdings Bhd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #505 globally with a market cap of $52.60 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #515 globally with a market cap of $51.87 Billion USD ( CN¥354.48 Billion CNY).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #548 globally with a market cap of $48.78 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #617 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #505 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #515 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $51.87 Billion | CN¥55.57 |
| #548 | GALDERMA GROUP AG | NYSE:GALDY | $48.78 Billion | $42.46 |
| #617 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €14.80 |
PeterLabs Holdings Bhd Historical Marketcap From 2015 to 2026
Between 2015 and today, PeterLabs Holdings Bhd's market cap moved from $16.69 Million to $ 15.89 Million, with a yearly change of 1.55%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | RM15.89 Million | -6.12% |
| 2025 | RM16.93 Million | +28.95% |
| 2024 | RM13.13 Million | -7.72% |
| 2023 | RM14.23 Million | +7.69% |
| 2022 | RM13.21 Million | -8.60% |
| 2021 | RM14.46 Million | -6.40% |
| 2020 | RM15.44 Million | +19.39% |
| 2019 | RM12.93 Million | -25.45% |
| 2018 | RM17.35 Million | -3.50% |
| 2017 | RM17.98 Million | +20.85% |
| 2016 | RM14.88 Million | -10.85% |
| 2015 | RM16.69 Million | -- |
End of Day Market Cap According to Different Sources
On Jul 21st, 2026 the market cap of PeterLabs Holdings Bhd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $15.89 Million USD |
| MoneyControl | $15.89 Million USD |
| MarketWatch | $15.89 Million USD |
| marketcap.company | $15.89 Million USD |
| Reuters | $15.89 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About PeterLabs Holdings Bhd
PeterLabs Holdings Berhad, an investment holding company, engages in manufacturing, distribution, trading, and export of animal health and nutrition products in Malaysia and internationally. The company operates through three segments: Manufacturing, Trading, and Others. It offers biosecurity products and disinfectants, compound feed supplements, feed additives, nutritional premixes, pharmaceutic… Read more